These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 19277005

  • 1. The cost-effectiveness of treatment of age-related macular degeneration: a review.
    Kymes Steven M.
    Minerva Med; 2009 Feb; 100(1):69-78. PubMed ID: 19277005
    [Abstract] [Full Text] [Related]

  • 2. Economic implications of current age-related macular degeneration treatments.
    Smiddy WE.
    Ophthalmology; 2009 Mar; 116(3):481-7. PubMed ID: 19157562
    [Abstract] [Full Text] [Related]

  • 3. Computerized model of cost-utility analysis for treatment of age-related macular degeneration.
    Fletcher EC, Lade RJ, Adewoyin T, Chong NV.
    Ophthalmology; 2008 Dec; 115(12):2192-8. PubMed ID: 18930556
    [Abstract] [Full Text] [Related]

  • 4. Age-related macular degeneration: the costs to society and the patient.
    Gupta OP, Brown GC, Brown MM.
    Curr Opin Ophthalmol; 2007 May; 18(3):201-5. PubMed ID: 17435426
    [Abstract] [Full Text] [Related]

  • 5. The cost of vision for vitreoretinal interventions.
    Smiddy WE.
    Curr Opin Ophthalmol; 2008 May; 19(3):195-201. PubMed ID: 18408493
    [Abstract] [Full Text] [Related]

  • 6. Quality of life and health economic assessments of age-related macular degeneration.
    Covert D, Berdeaux G, Mitchell J, Bradley C, Barnes R.
    Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S20-5. PubMed ID: 17240252
    [Abstract] [Full Text] [Related]

  • 7. Age-related macular degeneration: current and novel therapies.
    Prasad PS, Schwartz SD, Hubschman JP.
    Maturitas; 2010 May; 66(1):46-50. PubMed ID: 20219298
    [Abstract] [Full Text] [Related]

  • 8. The burden of age-related macular degeneration: a value-based analysis.
    Brown MM, Brown GC, Sharma S, Stein JD, Roth Z, Campanella J, Beauchamp GR.
    Curr Opin Ophthalmol; 2006 Jun; 17(3):257-66. PubMed ID: 16794438
    [Abstract] [Full Text] [Related]

  • 9. The comparative effectiveness and cost-effectiveness of vitreoretinal interventions.
    Brown MM, Brown GC, Brown HC, Irwin B, Brown KS.
    Curr Opin Ophthalmol; 2008 May; 19(3):202-7. PubMed ID: 18408494
    [Abstract] [Full Text] [Related]

  • 10. The rapidly evolving diagnosis and treatment of age-related macular degeneration.
    Optometry; 2009 Feb; 80(2):101-6. PubMed ID: 19195112
    [Abstract] [Full Text] [Related]

  • 11. An introduction to decision analysis in the economic evaluation of the prevention and treatment of vision-related diseases.
    Kymes SM.
    Ophthalmic Epidemiol; 2008 Feb; 15(2):76-83. PubMed ID: 18432490
    [Abstract] [Full Text] [Related]

  • 12. No efficacious treatment for age-related macular degeneration.
    Roodhooft J.
    Bull Soc Belge Ophtalmol; 2000 Feb; 276():83-92. PubMed ID: 10925530
    [Abstract] [Full Text] [Related]

  • 13. Update on utilities and cost-utility analyses.
    Hollands H, Sharma S.
    Curr Opin Ophthalmol; 2006 Jun; 17(3):223-7. PubMed ID: 16794433
    [Abstract] [Full Text] [Related]

  • 14. The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration.
    Grisanti S, Tatar O.
    Prog Retin Eye Res; 2008 Jul; 27(4):372-90. PubMed ID: 18621565
    [Abstract] [Full Text] [Related]

  • 15. Age-related macular degeneration: a practical approach to a challenging disease.
    Bourla DH, Young TA.
    J Am Geriatr Soc; 2006 Jul; 54(7):1130-5. PubMed ID: 16866687
    [Abstract] [Full Text] [Related]

  • 16. The burden of age-related macular degeneration.
    Schmier JK, Jones ML, Halpern MT.
    Pharmacoeconomics; 2006 Jul; 24(4):319-34. PubMed ID: 16605279
    [Abstract] [Full Text] [Related]

  • 17. [Combined intravitreal therapy for age-related macular disease].
    Koch F, Scholtz S, Singh P, Koss MJ.
    Klin Monbl Augenheilkd; 2008 Dec; 225(12):1003-8. PubMed ID: 19085777
    [Abstract] [Full Text] [Related]

  • 18. Age-related macular degeneration: diagnosis and management.
    Cook HL, Patel PJ, Tufail A.
    Br Med Bull; 2008 Dec; 85():127-49. PubMed ID: 18334518
    [Abstract] [Full Text] [Related]

  • 19. Impact of visual impairment on use of caregiving by individuals with age-related macular degeneration.
    Schmier JK, Halpern MT, Covert D, Delgado J, Sharma S.
    Retina; 2006 Dec; 26(9):1056-62. PubMed ID: 17151494
    [Abstract] [Full Text] [Related]

  • 20. Nutritional supplements in the prevention of age-related macular degeneration.
    Blodi BA.
    Insight; 2004 Dec; 29(1):15-6; quiz 17-8. PubMed ID: 15077399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.